<DOC>
	<DOCNO>NCT02529878</DOCNO>
	<brief_summary>The prognosis metastatic gastric cancer poor . Chemotherapy occasionally convert initially unresectable gastric cancer resectable cancer . Previous study show patient unresectable gastric cancer may obtain survival benefit chemotherapy subsequent curative surgery . The key conversion therapy initially unresectable metastatic GC high response rate . Apatinib , novel target inhibitor VEGF receptor 2 ( VEGFR2 ) , show significant antitumor activity patient GC . The purpose study investigate efficacy safety S1/Paclitaxel chemotherapy plus Apatinib conversion therapy metastatic gastric cancer .</brief_summary>
	<brief_title>Study Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib Unresectable Gastric Cancer</brief_title>
	<detailed_description>The investigator apply SPA regimen coversional therapy abtain high response rate . Paclitaxel：150 mg/m2 i.v.3h , give first day . Apatinib , oral , initial dose :500mg , QD , meal ( try take medicine time day ) . Dose adjustment : Down-regulate dosage 250 mg per day first time . If patient totally recovers toxic reaction regulation , could up-regulate dosage back former level . If down-regulation occur accord protocol , up-regulation forbidden . S-1 dosage : According body surface area , initial dosage S-1 decide follow criterion . Take medicine twice daily ( breakfast supper ) 2 week , suspend 1 week . Preventive medication : To prevent serious allergic reaction Paclitaxel , preventive medication give advance . We usually give dexamethasone 20mg orally 12 6 hour Paclitaxel , diphenhydramine ( something analogous ) 50 mg , cimetidine 300mg ( ranitidine 50mg ) I.V . 30-60 minute Paclitaxel . Repeat therapeutic schedule every 3 week . 3 cycle neoadjuvant chemotherapy surgery , stop Apatinib last cycle . 3 cycle adjuvant chemotherapy include S-1 Apatinib 4 6 week surgery .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>unresectable gastric cancer prove histologically ( AJCC , version 7 ) follow condition : unable radical excision due local metastasis invasion metastasis lymph node beside abdominal aorta , nonextensive metastasis liver ( three metastatic foci radical excision ) , Peritoneal metastasis ( CY1 , P1 , P2 ) , kukerburg tumor Definitely diagnose stage gastric cancer operation via CT MRI , ultrasonic endoscopy , PETCT , laparoscopic exploration necessary Untreated ( e.g . radiotherapy , chemotherapy , target therapy immunotherapy ) Negative HER2 state ECOG ( Eastern Cooperative Oncology Group ) :0~2 Age : 18~75 year old Normal hemodynamic index recruitment ( include blood cell count liver/kidney function ) . For example : WBC＞4.0*109/L , NE＞1.5*109/L , PLT＞100*109/L , BIL＜1.5 time upper limit normal reference value , ALT AST＜2.5 time upper limit normal reference value , CRE＜1.2mg/dl Good cardiac function recruitment , seizure myocardial infarction past half year , controllable hypertension coronary heart disease Not concomitant uncontrollable benign disease recruitment ( e.g . infection kidney , lung liver ) Not participate clinical trial treatment Signed Informed Consent Form conform inclusion condition Distal metastasis lung , brain , bone Ever operation stomach Operation intolerance due systemic basic disease Ever administrate drug ( include TCM drug ) recruitment , guarantee progress accord study requirement recruitment Allergy drug protocol Pregnant lactate woman Women childbearing age pregnancy desire study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>gastric caner</keyword>
	<keyword>Apatinib</keyword>
	<keyword>S1</keyword>
	<keyword>conversion therapy</keyword>
	<keyword>metastatic gastric cancer</keyword>
</DOC>